المؤلفون: Spratt DE; University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA. Electronic address: daniel.spratt@uhhospitals.org., Liu VYT; Artera Inc., Los Altos, CA, USA., Jia AY; University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Royce TJ; Artera Inc., Los Altos, CA, USA., Sandler HM; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Pugh SL; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA; American College of Radiology, Philadelphia, PA, USA., Tran PT; University of Maryland/Greenebaum Cancer Center, Baltimore, MD, USA., Feng FY; University of California-San Francisco, San Francisco, CA, USA.

المصدر: European urology [Eur Urol] 2024 Jul 17. Date of Electronic Publication: 2024 Jul 17.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

المؤلفون: Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Cleveland, Ohio. Electronic address: Daniel.Spratt@uhhospitals.org., Liu VYT; Veracyte, Inc, South San Francisco, California., Michalski J; Department of Radiation Oncology, Washington University, St. Louis, Missouri., Davicioni E; Veracyte, Inc, South San Francisco, California., Berlin A; Princess Margaret Cancer Centre, Cancer Clinical Research Unit, Toronto, Ontario, Canada., Simko JP; Department of Pathology, UCSF Medical Center-Mount Zion, San Francisco, California., Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Tran PT; Department of Pathology, University of Maryland, Baltimore, Maryland., Sandler HM; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California., Hall WA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Thompson DJS; Veracyte, Inc, South San Francisco, California., Parliament MB; Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada., Dayes IS; Division of Radiation Oncology, Hamilton Regional Cancer Centre, Ontario, Canada., Correa RJM; Department of Oncology, London Regional Cancer Program, Ontario, Canada., Robertson JM; Department of Radiation Oncology, Beaumont Health CCOP, Royal Oak, Michigan., Gore EM; Department of Radiation Oncology, Milwaukee VA Medical Center, Milwaukee, Wisconsin., Doncals DE; Division of Radiation Oncology, Akron City Hospital, Akron, Ohio., Vigneault E; Department of Radiation Oncology, CHU de Quebec Universite Laval, Quebec, Canada., Souhami L; Department of Radiation Oncology, Cedars Cancer Centre, McGill University, Quebec, Canada., Karrison TG; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania., Feng FY; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Oct 01; Vol. 117 (2), pp. 370-377. Date of Electronic Publication: 2023 May 02.

نوع المنشور: Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/radiotherapy, Male ; Humans ; Prostate-Specific Antigen ; Androgen Antagonists ; Retrospective Studies ; Neoplasm Grading ; Genomics ; Disease Progression

المؤلفون: Patel N; Department of Urology, Institute of Urologic Oncology, University of California, Los Angeles, Los Angeles, California, USA., Hakansson A; Veracyte, Inc, South San Francisco, California, USA., Ohtake S; Department of Urology, Institute of Urologic Oncology, University of California, Los Angeles, Los Angeles, California, USA., Muraki P; Department of Urology, Institute of Urologic Oncology, University of California, Los Angeles, Los Angeles, California, USA., Proudfout JA; Veracyte, Inc, South San Francisco, California, USA., Liu Y; Veracyte, Inc, South San Francisco, California, USA., Webber L; Veracyte, Inc, South San Francisco, California, USA., Ibarra A; Veracyte, Inc, South San Francisco, California, USA., Liu VYT; Veracyte, Inc, South San Francisco, California, USA., Davicioni E; Veracyte, Inc, South San Francisco, California, USA., Chamie K; Department of Urology, Institute of Urologic Oncology, University of California, Los Angeles, Los Angeles, California, USA., Pantuck A; Department of Urology, Institute of Urologic Oncology, University of California, Los Angeles, Los Angeles, California, USA., Shuch B; Department of Urology, Institute of Urologic Oncology, University of California, Los Angeles, Los Angeles, California, USA.

المصدر: Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (5), pp. 6437-6444. Date of Electronic Publication: 2022 Nov 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/genetics , Carcinoma, Renal Cell*/surgery , Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/genetics , Kidney Neoplasms*/surgery , Kidney Neoplasms*/pathology, Humans ; Transcriptome ; Neoplasm Staging ; Risk Factors ; Nephrectomy ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Prognosis

المؤلفون: Dal Pra A; Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, USA; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: alan.dalpra@med.miami.edu., Ghadjar P; Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Radiation Oncology, Kantonsspital Winterthur, Winterthur, Switzerland., Hayoz S; SAKK Coordinating Center, Bern, Switzerland., Liu VYT; Decipher Biosciences (a subsidiary of Veracyte Inc.), San Diego, USA., Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, USA., Thompson DJS; Emmes Canada, Vancouver, Canada., Davicioni E; Decipher Biosciences (a subsidiary of Veracyte Inc.), San Diego, USA., Huang HC; Decipher Biosciences (a subsidiary of Veracyte Inc.), San Diego, USA., Zhao X; Decipher Biosciences (a subsidiary of Veracyte Inc.), San Diego, USA., Liu Y; Decipher Biosciences (a subsidiary of Veracyte Inc.), San Diego, USA., Schär C; SAKK Coordinating Center, Bern, Switzerland., Gut P; Kantonsspital Luzern, Luzern, Switzerland., Plasswilm L; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Kantonsspital St. Gallen, St. Gallen, Switzerland., Hölscher T; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Polat B; Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany., Hildebrandt G; University Hospital Rostock, Rostock, Germany., Müller AC; University Hospital Tübingen, Tübingen, Germany., Pollack A; Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, USA., Thalmann GN; Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Zwahlen D; Department of Radiation Oncology, Kantonsspital Winterthur, Winterthur, Switzerland., Aebersold DM; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 Sep; Vol. 33 (9), pp. 950-958. Date of Electronic Publication: 2022 May 28.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Prostate-Specific Antigen* , Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/surgery , Salvage Therapy*/methods, Genomics ; Hormones ; Humans ; Male ; Neoplasm Recurrence, Local/radiotherapy ; Prostatectomy ; Retrospective Studies

المؤلفون: Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas Texas., de Jong JJ; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Liu VYT; Veracyte Inc., Vancouver, British Columbia, Canada., Bismar TA; Department of Pathology and Laboratory Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada., Boorjian SA; Mayo Clinic, Rochester, Minnesota., Huang HC; Veracyte Inc., Vancouver, British Columbia, Canada., Davicioni E; Veracyte Inc., Vancouver, British Columbia, Canada., Mian OY; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, Ohio., Wright JL; Department of Urology, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington., Necchi A; Vita-Salute San Raffaele University, Milan, Italy.; IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy., Dall'Era MA; Department of Urologic Surgery, UC Davis Health, Davis, California., Kaimakliotis HZ; Department of Urology, Indiana University, Indianapolis, Indiana., Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Gibb EA; Veracyte Inc., Vancouver, British Columbia, Canada., Boormans JL; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

المصدر: The Journal of urology [J Urol] 2022 Mar; Vol. 207 (3), pp. 541-550. Date of Electronic Publication: 2021 Oct 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Cisplatin/*therapeutic use , Neoplasm Invasiveness/*pathology , Urinary Bladder Neoplasms/*drug therapy , Urinary Bladder Neoplasms/*pathology, Aged ; Biomarkers, Tumor ; Chemotherapy, Adjuvant ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Staging ; Survival Rate ; Urinary Bladder Neoplasms/genetics ; Urinary Bladder Neoplasms/mortality

المؤلفون: Shahait M; Department of Surgery King Hussein Cancer Center Amman Jordan., Liu VYT; Decipher Biosciences San Diego CA USA., Vapiwala N; Department of Radiation Oncology Perelman School of Medicine University of Pennsylvania Philadelphia PA USA., Lal P; Department of Pathology Perelman School of Medicine University of Pennsylvania Philadelphia PA USA., Kim J; Department of Surgery University of Pennsylvania Philadelphia PA USA., Trabulsi EJ; Thomas Jefferson University Hospital Philadelphia PA USA., Huang HC; Decipher Biosciences San Diego CA USA., Davicioni E; Decipher Biosciences San Diego CA USA., Thompson DJS; EMMES Canada Vancouver BC Canada., Spratt D; University of Michigan Ann Arbor MI USA., Den RB; Thomas Jefferson University Hospital Philadelphia PA USA., Lee DI; Department of Surgery University of Pennsylvania Philadelphia PA USA.; Penn Urology Penn Presbyterian Medical Center Philadelphia PA USA.

المصدر: BJUI compass [BJUI Compass] 2021 Jan 24; Vol. 2 (4), pp. 267-274. Date of Electronic Publication: 2021 Jan 24 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101764975 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-4526 (Electronic) Linking ISSN: 26884526 NLM ISO Abbreviation: BJUI Compass Subsets: PubMed not MEDLINE